MAPT and non-small cell lung carcinoma: In NSCLC samples, STYXL1, ATXN2L, UBAP2L, GRB7, DDX25, CTSG, SSB, CAPRIN1, CIRBP, DCP1A, ELAVL1, TIA1, EIF4G1, PRRC2C, MAPT, DHX9, OGFOD1, DDX3X, CSDE1, HABP4, PRKAA2, CELF1, DYRK3, DDX1 were significantly dysregulated in NSCLC.